Abstract
The D-antigen ELISA is the commonly accepted test for release of inactivated poliovirus containing vaccines. However, this test has a few drawbacks regarding the many variations in the method to quantify the D-unit. The result may depend on method and reagents used which makes standardization of inactivated polio vaccines, based on D-units, to a real challenge. This chapter describes a surface plasmon resonance based method to quantify D-units. The advantage of the calibrated D-antigen assay is the decrease in test variations because no labels, [no incubation times] and no washing steps are necessary. For standardization of both IPV and Sabin IPV, the calibration free concentration analysis could be an improvement as compared to ELISA or other SPR methods because this method combines quantity (particle concentration) and quality (antigenicity) in one assay.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wood DJ, Heath AB, Kersten GF et al (1997) A new WHO International Reference Reagent for use in potency assays of inactivated poliomyelitis vaccine. Biologicals 25:59–64
van Steenis G, van Wezel AL, Sekhuis VM (1981) Potency testing of killed polio vaccine in rats. Dev Biol Stand 47:119–128
Bevilacqua JM, Young L, Chiu SW et al (1996) Rat immunogenicity assay of inactivated poliovirus. Dev Biol Stand 86:121–127
Guideline on waiving the in vivo assay of poliomyelitis vaccine (inactivated) and its combinations. In: European Pharmacopoeia. 2720 7th ed: EDQM
Morgeaux S, Milne C, Daas A (2005) Feasibility study to develop a common in vitro D antigen assay for inactivated poliomyelitis vaccines. Pharmeuropa Bio 2005:19–26
Westdijk J, Brugmans D, Martin J et al (2011) Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccines. Vaccine 29:3390–3397
Wood DJ, Heath AB, Sawyer LA (1995) A WHO collaborative study on assays of the antigenic content of inactivated poliovirus vaccines. Biologicals 23:83–94
Bakker WA, Thomassen YE, Van’t Oever AG et al (2011) Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV. Vaccine 29:7188–7196
Biacore concentration analysis handbook, BR1005-12 Edition AB/01-2007, GE Healthcare
van der Merwe PA (2001) Surface plasmon resonance in protein-ligand interactions. Oxford University Press, London
Koch F, Koch G (1985) The molecular biology of poliovirus. Springer-Verlag Wien, New York
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Westdijk, J., van der Maas, L., ten Have, R., Kersten, G. (2016). Measuring Poliovirus Antigenicity by Surface Plasmon Resonance. Application for Potency Indicating Assays. In: MartÃn, J. (eds) Poliovirus. Methods in Molecular Biology, vol 1387. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3292-4_16
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3292-4_16
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3291-7
Online ISBN: 978-1-4939-3292-4
eBook Packages: Springer Protocols